Skip to main content
letter
. 2014 Oct 30;74(1):317–319. doi: 10.1136/annrheumdis-2014-206483

Table 2.

ELISA results

Seropositive APS (n=40) SN-APS (n=40)
Standard ELISAs
 No. (%) testing positive for IgG anti-CL 18 (45%) 0
 No. (%) testing positive for IgG anti-β2GPI 6 (15%) 0
 No. (%) testing positive for IgM anti-CL 4 (10%) 0
 No. (%) testing positive for IgM anti-β2GPI 9 (22.5%) 0
Anti-DI ELISAs
 No. (%) testing positive for IgG anti-DI 11 (27.5%) 3 (7.5%)*
 No. (%) testing positive for IgM anti-DI 9 (22.5%) 0
 No. (%) testing positive for IgA anti-DI 7 (17.5%) 0
Other IgA ELISAs
 No. (%) testing positive for IgA anti-CL 12 (30%) 0
 No. (%) testing positive for IgA anti-β2GPI 8 (20%) 1 (2.5%)*

The cut-off for positive in each assay was defined as 99th centile of the healthy control population.

*The titres of IgG anti-DI in the three positive patients were 16 absorbance units (AU), 15.3 AU and 22.2 AU respectively compared with the positive cut-off of 10 AU. The titre of IgA anti-β2GPI in the one positive patient was 16 AU compared with a positive cut-off of 9 AU.

anti-β2GPI, anti-β-2-glycoprotein; CL, cardiolipin; DI, domain I; Ig, immunoglobulin; SN-APS, seronegative antiphospholipid syndrome.